Jonathan Jazayeri
About Jonathan Jazayeri
Jonathan Jazayeri is the Executive Director of Global Regulatory Affairs at Kite Pharma, where he has worked since 2021. He has extensive experience in regulatory affairs, having held positions at several major pharmaceutical companies and engaged in innovative regulatory strategies for therapeutic products.
Current Role at Kite Pharma
Jonathan Jazayeri serves as the Executive Director of Global Regulatory Affairs at Kite Pharma since 2021. In this role, he leads regulatory strategy for various projects, ensuring compliance with global regulatory requirements. He is responsible for overseeing the regulatory project teams and developing strategies that align with Kite Pharma's objectives in the biopharmaceutical sector.
Previous Experience in Regulatory Affairs
Prior to his current position, Jonathan Jazayeri held several roles in regulatory affairs across prominent pharmaceutical companies. He worked at Vertex Pharmaceuticals from 2012 to 2014, where he contributed to regulatory strategies. He also served as the Global Indication Lead for Immuno-Oncology at AstraZeneca in 2019 and as the Regulatory Affairs Director - Oncology from 2014 to 2019. His experience includes roles at GSK and MedImmune, focusing on oncology regulatory affairs.
Educational Background
Jonathan Jazayeri completed his Bachelor of Science in Pharmacology at UC Santa Barbara from 2003 to 2007. He then pursued advanced studies at the University of Southern California School of Pharmacy, where he earned a Doctorate in Pharmacy and a Master of Science in Regulatory Science between 2007 and 2011. His educational background provides a strong foundation for his expertise in regulatory affairs.
Regulatory Strategy Implementation
Throughout his career, Jonathan Jazayeri has successfully implemented innovative regulatory strategies. He has worked on obtaining fast track, breakthrough therapy, and orphan drug designations for various therapeutic products. His expertise extends to developing regulatory strategies for targeted therapies, immuno-oncology, antibody-drug conjugates (ADCs), and cell-based therapies.
Internship Experience
Jonathan Jazayeri gained early experience in regulatory affairs through internships. He worked as an intern at the FDA in 2011 for two months, which provided him with insights into regulatory processes. Additionally, he completed a graduate internship at Amgen in 2010, further enhancing his knowledge in the field.